Thank you for responding. I was under the impression that data will be out in 2018 which isn't that far off. Yes they need cash and will likely have to dilute a bit to keep them going at least until the data but if it's positive, the stock price should move significantly higher from where it is now so raising capital without diluting too much could be achieved or, in a more likely scenario, they would partner or be bought out. I think they have a good change at having successful data based on what i have read and they certainly have top notch guys working on the trial. At these levels i think it's worth the risk. Yeah it could drop further if they raise but i don't know how much more it could drop and the potential upside is enormous versus the downside.
"Don't worry about the world coming to an end today. It's already tomorrow in Australia"
